A citation-based method for searching scientific literature

Meiling Huang, Changjiao Yan, Jingjing Xiao, Ting Wang, Rui Ling. Diagn Pathol 2019
Times Cited: 12







List of co-cited articles
54 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity



2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.
Bryan R Haugen, Erik K Alexander, Keith C Bible, Gerard M Doherty, Susan J Mandel, Yuri E Nikiforov, Furio Pacini, Gregory W Randolph, Anna M Sawka, Martin Schlumberger,[...]. Thyroid 2016
58


RAS mutations in thyroid cancer.
Gina M Howell, Steven P Hodak, Linwah Yip. Oncologist 2013
104
33

TERT promoter mutations and their association with BRAF V600E mutation and aggressive clinicopathological characteristics of thyroid cancer.
Xiaoli Liu, Shen Qu, Rengyun Liu, Chunjun Sheng, Xiaoguang Shi, Guangwu Zhu, Avaniyapuram Kannan Murugan, Haixia Guan, Hongyu Yu, Yangang Wang,[...]. J Clin Endocrinol Metab 2014
183
33



BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients.
Langping Jin, Endong Chen, Siyang Dong, Yefeng Cai, Xiangjian Zhang, Yili Zhou, Ruichao Zeng, Fan Yang, Chuanmeng Pan, Yehuan Liu,[...]. Oncotarget 2016
76
25

Concomitant RAS, RET/PTC, or BRAF mutations in advanced stage of papillary thyroid carcinoma.
Minjing Zou, Essa Y Baitei, Ali S Alzahrani, Faisal S BinHumaid, Dania Alkhafaji, Roua A Al-Rijjal, Brian F Meyer, Yufei Shi. Thyroid 2014
57
25

BRAF V600E and TERT promoter mutations cooperatively identify the most aggressive papillary thyroid cancer with highest recurrence.
Mingzhao Xing, Rengyun Liu, Xiaoli Liu, Avaniyapuram Kannan Murugan, Guangwu Zhu, Martha A Zeiger, Sara Pai, Justin Bishop. J Clin Oncol 2014
390
25

Biologic and Clinical Perspectives on Thyroid Cancer.
James A Fagin, Samuel A Wells. N Engl J Med 2016
327
25

Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers.
Iñigo Landa, Tihana Ibrahimpasic, Laura Boucai, Rileen Sinha, Jeffrey A Knauf, Ronak H Shah, Snjezana Dogan, Julio C Ricarte-Filho, Gnana P Krishnamoorthy, Bin Xu,[...]. J Clin Invest 2016
478
25

Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology.
Yuri E Nikiforov, Sally E Carty, Simon I Chiosea, Christopher Coyne, Umamaheswar Duvvuri, Robert L Ferris, William E Gooding, Shane O LeBeau, N Paul Ohori, Raja R Seethala,[...]. Thyroid 2015
225
16

Genetic landscape of papillary thyroid carcinoma in the Chinese population.
Jialong Liang, Wanshi Cai, Dongdong Feng, Huajing Teng, Fengbiao Mao, Yi Jiang, Shanshan Hu, Xianfeng Li, Yujie Zhang, Baoguo Liu,[...]. J Pathol 2018
53
16

Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
A Greco, C Miranda, M A Pierotti. Mol Cell Endocrinol 2010
118
16

Recent incidences and differential trends of thyroid cancer in the USA.
Yushan Mao, Mingzhao Xing. Endocr Relat Cancer 2016
114
16


Thyroid cancer.
Tobias Carling, Robert Udelsman. Annu Rev Med 2014
157
16

BRAF V600E mutation and its association with clinicopathological features of papillary thyroid cancer: a meta-analysis.
Carol Li, Kathleen C Lee, Eric B Schneider, Martha A Zeiger. J Clin Endocrinol Metab 2012
166
16

Association of TERT promoter mutation 1,295,228 C>T with BRAF V600E mutation, older patient age, and distant metastasis in anaplastic thyroid cancer.
Xiaoguang Shi, Rengyun Liu, Shen Qu, Guangwu Zhu, Justin Bishop, Xiaoli Liu, Hui Sun, Zhongyan Shan, Enhua Wang, Yahong Luo,[...]. J Clin Endocrinol Metab 2015
58
16

Correlation between the BRAF V600E mutation and tumor invasiveness in papillary thyroid carcinomas smaller than 20 millimeters: analysis of 1060 cases.
Fulvio Basolo, Liborio Torregrossa, Riccardo Giannini, Mario Miccoli, Cristiana Lupi, Elisa Sensi, Piero Berti, Rossella Elisei, Paolo Vitti, Angelo Baggiani,[...]. J Clin Endocrinol Metab 2010
127
16

Association of BRAFV600E mutation with clinicopathological features of papillary thyroid carcinoma: a study on a Chinese population.
Shu Liu, Bingfei Zhang, Yanru Zhao, Pu Chen, Meiju Ji, Peng Hou, Bingyin Shi. Int J Clin Exp Pathol 2014
16
16

Molecular Profile of Advanced Thyroid Carcinomas by Next-Generation Sequencing: Characterizing Tumors Beyond Diagnosis for Targeted Therapy.
Hui Chen, Rajyalakshmi Luthra, Mark J Routbort, Keyur P Patel, Maria E Cabanillas, Russell R Broaddus, Michelle D Williams. Mol Cancer Ther 2018
36
16

Mutational profile of advanced primary and metastatic radioactive iodine-refractory thyroid cancers reveals distinct pathogenetic roles for BRAF, PIK3CA, and AKT1.
Julio C Ricarte-Filho, Mabel Ryder, Dhananjay A Chitale, Michael Rivera, Adriana Heguy, Marc Ladanyi, Manickam Janakiraman, David Solit, Jeffrey A Knauf, R Michael Tuttle,[...]. Cancer Res 2009
357
16

Epithelial-to-mesenchymal transition in thyroid cancer: a comprehensive review.
Heewa Shakib, Sadegh Rajabi, Mohammad Hossien Dehghan, Farideh Jalali Mashayekhi, Nahid Safari-Alighiarloo, Mehdi Hedayati. Endocrine 2019
18
16

New Insights in Thyroid Cancer and p53 Family Proteins.
Livia Manzella, Stefania Stella, Maria Stella Pennisi, Elena Tirrò, Michele Massimino, Chiara Romano, Adriana Puma, Martina Tavarelli, Paolo Vigneri. Int J Mol Sci 2017
38
16

Vandetanib in locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 2 trial.
Sophie Leboulleux, Lars Bastholt, Thomas Krause, Christelle de la Fouchardiere, Jan Tennvall, Ahmad Awada, José Manuel Gómez, Françoise Bonichon, Laurence Leenhardt, Christine Soufflet,[...]. Lancet Oncol 2012
225
16

Silencing of hypoxia-inducible factor-1α promotes thyroid cancer cell apoptosis and inhibits invasion by downregulating WWP2, WWP9, VEGF and VEGFR2.
Zhong-Yang Ding, Yun-Juan Huang, Jian-Dong Tang, Gan Li, Pan-Qiang Jiang, Hao-Tian Wu. Exp Ther Med 2016
13
16

Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Hyeyeun Lim, Susan S Devesa, Julie A Sosa, David Check, Cari M Kitahara. JAMA 2017
753
16

Thyroid cancer.
Maria E Cabanillas, David G McFadden, Cosimo Durante. Lancet 2016
463
16

Progress in molecular-based management of differentiated thyroid cancer.
Mingzhao Xing, Bryan R Haugen, Martin Schlumberger. Lancet 2013
329
16

Prognostic implication of BRAF and TERT promoter mutation combination in papillary thyroid carcinoma-A meta-analysis.
Huy Gia Vuong, Ahmed M A Altibi, Uyen N P Duong, Lewis Hassell. Clin Endocrinol (Oxf) 2017
50
16

TERT Promoter Mutation Predicts Radioiodine-Refractory Character in Distant Metastatic Differentiated Thyroid Cancer.
Xue Yang, Jiao Li, Xiaoyi Li, Zhiyong Liang, Wen Gao, Jun Liang, Shujun Cheng, Yansong Lin. J Nucl Med 2017
43
16

Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid Cancers.
Nikita Pozdeyev, Laurie M Gay, Ethan S Sokol, Ryan Hartmaier, Kelsi E Deaver, Stephanie Davis, Jena D French, Pierre Vanden Borre, Daniel V LaBarbera, Aik-Choon Tan,[...]. Clin Cancer Res 2018
164
16

Prognostic Significance of TERT Promoter Mutations in Papillary Thyroid Carcinomas in a BRAF(V600E) Mutation-Prevalent Population.
Seung Eun Lee, Tae Sook Hwang, Yoon-La Choi, Hye Seung Han, Wan Seop Kim, Min Hye Jang, Suk Kyeong Kim, Jung Hyun Yang. Thyroid 2016
42
16

A Review of Driver Genetic Alterations in Thyroid Cancers.
Fatemeh Khatami, Seyed Mohammad Tavangar. Iran J Pathol 2018
7
28

Regulation of mutant TERT by BRAF V600E/MAP kinase pathway through FOS/GABP in human cancer.
Rengyun Liu, Tao Zhang, Guangwu Zhu, Mingzhao Xing. Nat Commun 2018
83
16

TERT promoter mutations in thyroid cancer.
Rengyun Liu, Mingzhao Xing. Endocr Relat Cancer 2016
183
16

Comprehensive survey of HRAS, KRAS, and NRAS mutations in proliferative thyroid lesions from an ethnically diverse population.
Hans-Juergen Schulten, Sherine Salama, Alaa Al-Ahmadi, Zuhoor Al-Mansouri, Zeenat Mirza, Khalid Al-Ghamdi, Osman Abdel Al-Hamour, Etimad Huwait, Mamdooh Gari, Mohammad Hussain Al-Qahtani,[...]. Anticancer Res 2013
28
16

Preoperative detection of TERT promoter and BRAFV600E mutations in papillary thyroid carcinoma in high-risk thyroid nodules.
Tatiana Marina Vieira Giorgenon, Fabiane Tavares Carrijo, Maurício Alamos Arruda, Taíse Lima Oliveira Cerqueira, Haiara Ramos Barreto, Juliana Brandão Cabral, Thiago Magalhães da Silva, Patrícia Künzle Ribeiro Magalhães, Léa Maria Zanini Maciel, Helton Estrela Ramos. Arch Endocrinol Metab 2019
8
25

Co-existence of BRAFV600E and TERT promoter mutations in papillary thyroid carcinoma is associated with tumor aggressiveness, but not with lymph node metastasis.
Haoyu Ren, Yifan Shen, Daixing Hu, Wei He, Jing Zhou, Yijia Cao, Yu Mao, Yi Dou, Wei Xiong, Qi Xiao,[...]. Cancer Manag Res 2018
20
16

BRAF V600E and TERT Promoter Mutations in Papillary Thyroid Carcinoma in Chinese Patients.
Jian Sun, Jing Zhang, Junliang Lu, Jie Gao, Xinyu Ren, Lianghong Teng, Huanli Duan, Yansong Lin, Xiaoyi Li, Bo Zhang,[...]. PLoS One 2016
30
16

Interaction of BRAF-induced ETS factors with mutant TERT promoter in papillary thyroid cancer.
Young Shin Song, Seong-Keun Yoo, Hwan Hee Kim, Gyeongseo Jung, Ah-Reum Oh, Ji-Young Cha, Su-Jin Kim, Sun Wook Cho, Kyu Eun Lee, Jeong-Sun Seo,[...]. Endocr Relat Cancer 2019
25
16

Association between BRAF V600E mutation and mortality in patients with papillary thyroid cancer.
Mingzhao Xing, Ali S Alzahrani, Kathryn A Carson, David Viola, Rossella Elisei, Bela Bendlova, Linwah Yip, Caterina Mian, Federica Vianello, R Michael Tuttle,[...]. JAMA 2013
549
16

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis.
Ralph P Tufano, Gilberto V Teixeira, Justin Bishop, Kathryn A Carson, Mingzhao Xing. Medicine (Baltimore) 2012
201
16

BRAF mutation testing of thyroid fine-needle aspiration biopsy specimens for preoperative risk stratification in papillary thyroid cancer.
Mingzhao Xing, Douglas Clark, Haixia Guan, Meiju Ji, Alan Dackiw, Kathryn A Carson, Matthew Kim, Anthony Tufaro, Paul Ladenson, Martha Zeiger,[...]. J Clin Oncol 2009
199
16

BRAFV600E mutation does not serve as a prognostic factor in Korean patients with papillary thyroid carcinoma.
Dongbin Ahn, June Sik Park, Jin Ho Sohn, Jae Hyug Kim, Sun-Kyun Park, An Na Seo, Ji Young Park. Auris Nasus Larynx 2012
42
16

The association of the BRAF(V600E) mutation with prognostic factors and poor clinical outcome in papillary thyroid cancer: a meta-analysis.
Tae Hyuk Kim, Young Joo Park, Jung Ah Lim, Hwa Young Ahn, Eun Kyung Lee, You Jin Lee, Kyung Won Kim, Seo Kyung Hahn, Yeo Kyu Youn, Kwang Hyun Kim,[...]. Cancer 2012
291
16

TERT, BRAF, and NRAS in Primary Thyroid Cancer and Metastatic Disease.
Miguel Melo, Adriana Gaspar da Rocha, Rui Batista, João Vinagre, Maria João Martins, Gracinda Costa, Cristina Ribeiro, Francisco Carrilho, Valeriano Leite, Cláudia Lobo,[...]. J Clin Endocrinol Metab 2017
66
16

Relationship between BRAF V600E and clinical features in papillary thyroid carcinoma.
Changjiao Yan, Meiling Huang, Xin Li, Ting Wang, Rui Ling. Endocr Connect 2019
24
16


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.